Abstract
In 1982, the author discovered that when a patient holds a slide of a cancer cell that was identical to the cancer existing in the patient’s own body, the O-ring formed in the patient’s other hand will become markedly weak due to resonance phenomenon between two identical substances, few example between a microscope slide of adenocarcinoma of the lung and adenocarcinoma existing in the patient’s lung. But for the screening of cancer in the subject who has no symptoms or complaints of specific internal organs, this method required many cancer slides of different issues, as different internal organ tissues needed to be tested. In the late 1980’s, the author’s cancer slides sent by airmail from New York to Tokyo for a conference arrived as glass powder; therefore, the author began to look for an alternative approach that did not require each cancer slide of different organs, but instead he actively searched for the common parameters that co-exist in various types of cancer and pre-cancer. As a result, in the early 1990’s, the author found that the following substances co-exist in precancers and cancers:
Marked increase in Integrin α5β1 Marked increase in Oncogene C-fos Ab2 Marked increase in Hg Marked decrease in Acethylcholine (usually less than 1/1000 of the normal amount) Viral infection.
In addition, during 1996-1998, the following factors were also found in cancer and pre-cancer:
6. Marked decrease in NO (nitrogen monoxide), less than 1/1000 of normal 7. Marked increase in glucose uptake (Max: 2X blood glucose concentration) 8. Marked increase in Rb (Ab-8) 9. Marked increase in p53 (Ab-5) 10. Increase in basic unit of human Telomere TTAGGG (Max: 2X Normal Tissue Telomere TTAGGG, such cancers in the lung and colon, but in prostate cancer it can reach 4X of the normal tissue Telomere) 11. Increase in basic unit of human Telomere CCCTTA (Max: 2X Normal Tissue Telomere CCCTTA, such cancers in the lung and colon colon, but in prostate cancer it can reach 4X of the normal tissue Telomere).
Using Integrin α5β1 in the resonance phenomenon test, the author has detected many types of cancers and pre-cancers. Since the early 1990’s, the author succeeded in screening cancer at a distance without touching the patient in about 2 minutes, by projecting a red spectrum laser beam from a pocket laser pointer to the patient’s palms and lower extremities where the skin is exposed. When the resonance shows a strong positive, we localize the exact location, which used to take 30 minutes to 1 hour. However, since the summer of 1999, using a bar-type laser beam with Integrin α5β1 as the reference control substance in the test, the author not only is able to screen cancers and pre-cancers in the early stages but also localize the exact location by an X-Y scanning of the entire body in less than half an hour. When these locations are identified, the patient is sent to standard laboratory tests to try to confirm the findings. If the standard laboratory tests, such as cancer marker by blood test, X-ray, CT scan or MRI, fail to detect the Bi-Digital O-Ring Test positive finding for cancer or pre-cancer, the author considers this condition as pre-cancer. Even when standard laboratory tests are negative, the author recommends repeating the tests periodically, as some of the patients who did not repeat the laboratory tests developed cancer later on, and terminal cases were discovered from anywhere between 3-7 years later.
Using the Bi-Digital O-Ring Test, the author found that a mixture of EPA (Eicosa Pentaenoic Acid) and DHA (Docosa Hexanoic Acid) has a potentially strong antiviral effect and anti-cancer effect and when it is given with Selective Drug Uptake Enhancement Method, it inhibits further growth of cancer. In the abnormal presence of an excessive deposit of Hg in cancer cell nuclei, choromosomes will be greatly affected by the absorption of electromagnetic fields by these metals, and this will further contribute to the formation of abnormal genes. Therefore, removal of Hg from inside of the pre-cancer & cancer cells, particularly the Hg inside the cell nuclei, is a very important objective of the treatment. As a solution to this problem, the author discovered that Cilantro can remove Hg, Pb, and Al. By giving additional Cilantro (to remove metals from cancer tissue) together with EPA and DHA with Selective Drug Uptake Enhancement, to the cancer tissue or the metastatic tissue, the cancer often shrinks significantly.
Screening of potential cardiovascular problems is also performed using homocysteine as a control substance to detect resonance. Similarly, using the monoclonal anti-body of various viruses and bacteria, one is able to identify pathogenic factors using the Bi-Digital O-Ring Test Resonance Phenomenon between two identical substances. The author found that the major cause of intractable pain is due to Herpes Simplex Type I virus or occasionally Herpes Simplex Type II virus infection with or without bacterial infections. When the Selective Drug Uptake Enhancement Method is applied, more than 90% of the cases of intractable pain are eliminated by a mixture of EPA and DHA as an effective anti-viral agent and Cilantro to remove localized deposits of metal such as Hg, Pb & A1 (these metals inhibit anti-viral effects of EPA & DHA). Along with the administration of effective medication selected by the Bi-Digital O-Ring Test, the Selective Drug Uptake Enhancement Method, by various stimulation (including acupuncture, pinching, Shiatsu, (+) Qi Gong energy stored paper, heal including moxa, low pulse repetition rate electrical stimulation, a specific magnetic pole) of the accurate organ representation area corresponding to the pathological area, ensures that the medications will be delivered to the pathological areas selectively. By repeating this procedure each time medication is given and also giving stimulation in between times, and if one is able to maintain the drug uptake at a therapeutic level for 24 hours continuously, usually the therapeutic result is far superior to any other treatment, because if one simply gives effective medication, the only place the drug does not reach therapeutic levels is in the pathological areas.
There are many factors that inhibit drug uptake, among them are:
O-Ring Test-negative underwear, some of which are synthetic and dyed, and even natural cotton, if it is over whitened or dyed with substances harmful to the body. Labels attached to underwear. Most labels which touch the skin will inhibit drug uptake. Jewelry and metal watches contacting the skin, including bracelets, necklaces, and earrings, particularly those made of metal. Earrings, metal in mouth and eye glass often inhibit drug uptake in brain. Simultaneous multiple drug intake which results in drug interaction and canceling effects. Often cancer patients think that if they take more than 3 or 4 effective anti-cancer drugs, they will have a better chance of surviving. As a consequence, many patients take multiple known anti-cancer drugs, both medically approved and unapproved and often all the anticancer effects can be cancelled due to drug interaction. But with the Bi-Digital O-Ring Test, one can often correctly estimate the potential drug interactions and canceling effects, as well as the effectiveness of each medication and optimal dose before actually taking drugs. Cancelling effect of incompatible medications due to drug interaction among multiple drugs given at the same time to the patient. Pain medicine, such as non-steroidal antiinflammatory medicine often inhibits some of the anti-cancer effects of medication or antituberculosis medicine (i.e. Isoniazid). Isoniazid is not compatible with Amoxicillin, Doxycycline, EPA & DHA and Cilantro. When taken together, the effect of each medication will cancel each other. Touching right and left hands or right and left lower extremities together, including crossing of the legs. Exposure to environmental electromagnetic fields.
Thus, in order to have a successful therapeutic result, it is possible to select effective and compatible medications with minimum side effects on normal body tissues by selectively delivering effective drugs to the pathological internal organs, while markedly reducing drug uptake to the normal parts of the patient’s body.
Get full access to this article
View all access options for this article.